Cargando…

Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China’s top 3 hospital, 2009–2019

BACKGROUND: Cervical cancer is the fourth most common cancer in women. Early detection and diagnosis play an important role in secondary prevention of cervical cancer. This study aims to provide more information to develop an effective strategy for the prevention and control of cervical cancer in no...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yidi, Ang, Qing, Wu, Huan, Xu, Jingjiang, Chen, Defu, Zhao, Hongyou, Liu, Haolin, Guo, Xianghuan, Gu, Ying, Qiu, Haixia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359485/
https://www.ncbi.nlm.nih.gov/pubmed/32660490
http://dx.doi.org/10.1186/s12985-020-01383-1
_version_ 1783559060305477632
author Liu, Yidi
Ang, Qing
Wu, Huan
Xu, Jingjiang
Chen, Defu
Zhao, Hongyou
Liu, Haolin
Guo, Xianghuan
Gu, Ying
Qiu, Haixia
author_facet Liu, Yidi
Ang, Qing
Wu, Huan
Xu, Jingjiang
Chen, Defu
Zhao, Hongyou
Liu, Haolin
Guo, Xianghuan
Gu, Ying
Qiu, Haixia
author_sort Liu, Yidi
collection PubMed
description BACKGROUND: Cervical cancer is the fourth most common cancer in women. Early detection and diagnosis play an important role in secondary prevention of cervical cancer. This study aims to provide more information to develop an effective strategy for the prevention and control of cervical cancer in northern China. METHODS: A retrospective single-centre descriptive cross-sectional study was conducted in Chinese PLA General Hospital located in Beijing, covering the period from January 2009 to June 2019. The patients who underwent a polymerase chain reaction (PCR)-based HPV genotyping test and cervical pathological diagnosis were included. Furthermore, we limited the interval between the two examination within 180 days for the purpose of making sure their correlation to analyse their relationship. Moreover, the relationship between different cervical lesions and age as well as single/multiple HPV infection was assessed. RESULTS: A total of 3134 patients were eligible in this study after HPV genotyping test and pathological diagnosis. Most of the patients (95%) were from northern China. Among the patients, 1745(55.68%) had high-grade squamous intraepithelial neoplasia (HSIL), 1354 (43.20%) had low-grade squamous intraepithelial neoplasia (LSIL) and 35 (1.12%) were Normal. The mean age was 42.06 ± 10.82(range, 17–79 years). The women aged 35–49 years accounted for the highest incidence rate. The top five most commonly identified HPV genotypes in each lesion class were as follows: HPV16, 58, 52, 31 and 51 in the class of HSIL; HPV16, 52, 58, 56 and 51 in the class of LSIL; HPV16, 31, 6,11, 52 and 58 in the class of normal. The frequencies of HPV single genotype infection and multiple genotypes infection were 55.26 and 34.18%, respectively. There was no difference in the attributable proportions of multiple genotypes infection amongst HSIL, LSIL and Normal. CONCLUSIONS: In Northern China, HPV16 was the most dominant genotype in the patients with pathological examination. The peak age of the onset of HSIL was between 35 and 49 years of age. Infection with multiple HPV genotypes did not increase the risk of HSIL. Type-specific HPV prevalence and attribution proportion to cervical precancerous lesions should be taken into consideration in the development of vaccines and strategy for screening in this population.
format Online
Article
Text
id pubmed-7359485
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73594852020-07-17 Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China’s top 3 hospital, 2009–2019 Liu, Yidi Ang, Qing Wu, Huan Xu, Jingjiang Chen, Defu Zhao, Hongyou Liu, Haolin Guo, Xianghuan Gu, Ying Qiu, Haixia Virol J Research BACKGROUND: Cervical cancer is the fourth most common cancer in women. Early detection and diagnosis play an important role in secondary prevention of cervical cancer. This study aims to provide more information to develop an effective strategy for the prevention and control of cervical cancer in northern China. METHODS: A retrospective single-centre descriptive cross-sectional study was conducted in Chinese PLA General Hospital located in Beijing, covering the period from January 2009 to June 2019. The patients who underwent a polymerase chain reaction (PCR)-based HPV genotyping test and cervical pathological diagnosis were included. Furthermore, we limited the interval between the two examination within 180 days for the purpose of making sure their correlation to analyse their relationship. Moreover, the relationship between different cervical lesions and age as well as single/multiple HPV infection was assessed. RESULTS: A total of 3134 patients were eligible in this study after HPV genotyping test and pathological diagnosis. Most of the patients (95%) were from northern China. Among the patients, 1745(55.68%) had high-grade squamous intraepithelial neoplasia (HSIL), 1354 (43.20%) had low-grade squamous intraepithelial neoplasia (LSIL) and 35 (1.12%) were Normal. The mean age was 42.06 ± 10.82(range, 17–79 years). The women aged 35–49 years accounted for the highest incidence rate. The top five most commonly identified HPV genotypes in each lesion class were as follows: HPV16, 58, 52, 31 and 51 in the class of HSIL; HPV16, 52, 58, 56 and 51 in the class of LSIL; HPV16, 31, 6,11, 52 and 58 in the class of normal. The frequencies of HPV single genotype infection and multiple genotypes infection were 55.26 and 34.18%, respectively. There was no difference in the attributable proportions of multiple genotypes infection amongst HSIL, LSIL and Normal. CONCLUSIONS: In Northern China, HPV16 was the most dominant genotype in the patients with pathological examination. The peak age of the onset of HSIL was between 35 and 49 years of age. Infection with multiple HPV genotypes did not increase the risk of HSIL. Type-specific HPV prevalence and attribution proportion to cervical precancerous lesions should be taken into consideration in the development of vaccines and strategy for screening in this population. BioMed Central 2020-07-13 /pmc/articles/PMC7359485/ /pubmed/32660490 http://dx.doi.org/10.1186/s12985-020-01383-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Liu, Yidi
Ang, Qing
Wu, Huan
Xu, Jingjiang
Chen, Defu
Zhao, Hongyou
Liu, Haolin
Guo, Xianghuan
Gu, Ying
Qiu, Haixia
Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China’s top 3 hospital, 2009–2019
title Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China’s top 3 hospital, 2009–2019
title_full Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China’s top 3 hospital, 2009–2019
title_fullStr Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China’s top 3 hospital, 2009–2019
title_full_unstemmed Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China’s top 3 hospital, 2009–2019
title_short Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China’s top 3 hospital, 2009–2019
title_sort prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in beijing, china: analysis of results from china’s top 3 hospital, 2009–2019
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359485/
https://www.ncbi.nlm.nih.gov/pubmed/32660490
http://dx.doi.org/10.1186/s12985-020-01383-1
work_keys_str_mv AT liuyidi prevalenceofhumanpapillomavirusgenotypesandprecancerouscervicallesionsinascreeningpopulationinbeijingchinaanalysisofresultsfromchinastop3hospital20092019
AT angqing prevalenceofhumanpapillomavirusgenotypesandprecancerouscervicallesionsinascreeningpopulationinbeijingchinaanalysisofresultsfromchinastop3hospital20092019
AT wuhuan prevalenceofhumanpapillomavirusgenotypesandprecancerouscervicallesionsinascreeningpopulationinbeijingchinaanalysisofresultsfromchinastop3hospital20092019
AT xujingjiang prevalenceofhumanpapillomavirusgenotypesandprecancerouscervicallesionsinascreeningpopulationinbeijingchinaanalysisofresultsfromchinastop3hospital20092019
AT chendefu prevalenceofhumanpapillomavirusgenotypesandprecancerouscervicallesionsinascreeningpopulationinbeijingchinaanalysisofresultsfromchinastop3hospital20092019
AT zhaohongyou prevalenceofhumanpapillomavirusgenotypesandprecancerouscervicallesionsinascreeningpopulationinbeijingchinaanalysisofresultsfromchinastop3hospital20092019
AT liuhaolin prevalenceofhumanpapillomavirusgenotypesandprecancerouscervicallesionsinascreeningpopulationinbeijingchinaanalysisofresultsfromchinastop3hospital20092019
AT guoxianghuan prevalenceofhumanpapillomavirusgenotypesandprecancerouscervicallesionsinascreeningpopulationinbeijingchinaanalysisofresultsfromchinastop3hospital20092019
AT guying prevalenceofhumanpapillomavirusgenotypesandprecancerouscervicallesionsinascreeningpopulationinbeijingchinaanalysisofresultsfromchinastop3hospital20092019
AT qiuhaixia prevalenceofhumanpapillomavirusgenotypesandprecancerouscervicallesionsinascreeningpopulationinbeijingchinaanalysisofresultsfromchinastop3hospital20092019